Suppr超能文献

B 细胞淋巴瘤伴 IRF4 重排:13 例临床病理研究。

B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.

机构信息

Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Shanghai Histo Pathology Diagnosis Center, Shanghai, China.

出版信息

Pathol Int. 2021 Mar;71(3):183-190. doi: 10.1111/pin.13067. Epub 2021 Jan 27.

Abstract

Interferon regulatory factor 4 (IRF4) rearrangement is commonly detected in patients with a range of lymphoproliferative malignancies, including myelomas, large B cell lymphomas and low-grade B cell neoplasms. However, IRF4 rearrangement is generally a relatively rare finding in these latter two cancer types. In the present article, we describe and summarize the clinicopathological and genetic features of 13 cases of B cell lymphoma with IRF4 rearrangement, including 12 cases of large B cell lymphoma and one case of low-grade lymphoma exhibiting such rearrangement. These cases were detected in six females and seven males between 14 and 71 years of age. From a morphological perspective, large B cell lymphoma tumors included in this analysis exhibited large neoplastic cells in diffuse or follicular patterns, while the case of low-grade lymphoma mainly composed of small lymphocytes. All analyzed cases exhibited a split in the IRF4 gene consistent with IRF4 translocation. Three of six analyzed large B cell lymphoma cases harbored IGLL5 mutations. Mutations in SAMHD1 were detected in the low-grade lymphoma with IRF4 rearrangement case. In summary, our results offer further insight into the morphological and molecular heterogeneity of cases of B cell lymphoma exhibiting IRF4 rearrangements.

摘要

干扰素调节因子 4(IRF4)重排常见于多种淋巴增殖性恶性肿瘤患者,包括骨髓瘤、大 B 细胞淋巴瘤和低级别 B 细胞肿瘤。然而,IRF4 重排在后两种癌症类型中通常是一种相对罕见的发现。在本文中,我们描述并总结了 13 例具有 IRF4 重排的 B 细胞淋巴瘤的临床病理和遗传学特征,包括 12 例大 B 细胞淋巴瘤和 1 例具有这种重排的低级别淋巴瘤。这些病例发生于 6 名女性和 7 名男性,年龄 14 至 71 岁。从形态学角度来看,本分析中包含的大 B 细胞淋巴瘤肿瘤表现为弥漫性或滤泡性的大肿瘤细胞,而低级别淋巴瘤主要由小淋巴细胞组成。所有分析的病例均表现出与 IRF4 易位一致的 IRF4 基因分裂。在 6 例分析的大 B 细胞淋巴瘤病例中,有 3 例存在 IGLL5 突变。具有 IRF4 重排的低级别淋巴瘤中检测到 SAMHD1 突变。总之,我们的结果进一步深入了解了具有 IRF4 重排的 B 细胞淋巴瘤病例的形态和分子异质性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验